Vigneri, R., Malandrino, P. & Vigneri, P. The changing epidemiology of thyroid cancer: why is incidence increasing? Curr. Opin. Oncol. 27, 1-7 (2015).
 Silberstein, E. B., et al. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J. Nucl. Med.53, 1633-1651 (2012).
 Sawka, A. M., et al. American Thyroid Association Guidelines and Statements: Past, Present, and Future. Thyroid. 28, 692-706 (2018).
 Alan Selcuk, N., Toklu, T., Beykan, S. & Karaaslan, S. I. Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer. J. Appl. Clin. Med. Phys. 19, 134-140 (2018).
 Loevinger, R., et al. A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides, MIRD Pamphlet No. 1 Revised. The Society of Nuclear Medicine. 1976.
 Agostini, D., et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur. J. Nucl. Med. Mol. Imaging35, 535-546 (2008).
 Boening, G., Pretorius, P. H. & King, M. A. Study of relative quantification of Tc-99 m with partial volume effect and spillover correction for SPECT oncology imaging. IEEE Transactions Nuclear Sci.53, 1205-1212 (2006).
 Hellman, R. S., et al. Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. Radiology172, 183-188 (1989).
 Vija, A. H., et al. ROC study and SUV threshold using quantitative multi-modal SPECT for bone imaging. Eur. J. Hybrid Imaging3, 10 (2019).
 Koizumi, M., et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann. Nuclear Med. 29, 138-148 (2015).
 Ogura, I., et al. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis. Ann. Nuclear Med. 33, 776-782 (2019).
 Dickson, J., Ross, J. & Voo, S. Quantitative SPECT: the time is now. EJNMMI Phys.6, 4 (2019).
 Romain De Laroche, P. R., et al. Therapeutic response assessment of bone metastatic prostate carcinoma treated by abiraterone using x-SPECT Quant®: preliminary results. J. Nucl. Med. 57, 1422 (2016).
 van Gils, K., Brinks, P., Lavalaye, J., Verberne, H. J. & Habraken, J. B. A. A method to measure the absorbed dose of the thyroid during I-131 therapy, using a collar detector system and a SPECT acquisition. Med. Phys. 44, 5450-5456 (2017).
 Minguez, P., et al. Whole-remnant and maximum-voxel SPECT/CT dosimetry in (131) 131I-NaI treatments of differentiated thyroid cancer. Med. Phys. 43, 5279-5287 (2016).
 Team RdC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; (2012).